Recombinant human erythropoietin - Uni-Bio Science Group

Drug Profile

Recombinant human erythropoietin - Uni-Bio Science Group

Alternative Names: rhEPO-Fc; Uni-EPO-Fc

Latest Information Update: 21 May 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Uni-Bio Science Group
  • Class Antianaemics; Recombinant erythropoietins; Recombinant fusion proteins
  • Mechanism of Action Erythropoiesis stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase I Anaemia

Most Recent Events

  • 27 Mar 2017 Uni Bio Science Group completes a phase I trial in Anaemia in China
  • 01 Jun 2015 Phase-I clinical trials in Anaemia in China (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top